MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from short-term investm...
Share-based payments
Prepaids
Others
Negative Cash Flow Breakdown
Purchase of short-term investmen...
Net loss for the period
Accounts payable and accrued lia...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Share-based payments
3,240,107
Net loss for the period
-18,909,992
Amortization of right-of-use asset
63,836
Accrued investment income
-89,126
Receivables
112,456
Prepaids
-286,517
Operating lease liability
-85,796
Accounts payable and accrued liabilities
-1,577,018
Accretion of lease liability
19,819
Accretion of premiums/discounts on short-term investments, net
501,314
Termination of lease (note 7)
31,648
Net cash used in operating activities
-17,518,819
Proceeds from short-term investments sold
29,225,000
Purchase of short-term investments
29,463,131
Net cash provided by (used in) investing activities
-238,131
Options exercised
0
Shares purchased through employee share purchase plan
0
Net cash provided by financing activities
0
Effect of foreign exchange on cash and cash equivalents
0
Change in cash and cash equivalents for the period
-17,756,950
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Change in cash and cash
equivalents for the period
-$17,756,950
Share-based payments
$3,240,107
Prepaids
-$286,517
Accrued investment
income
-$89,126
Amortization of right-of-use
asset
$63,836
Accretion of lease
liability
$19,819
Proceeds from short-term
investments sold
$29,225,000
Net cash used in
operating activities
-$17,518,819
Net cash provided by
(used in) investing...
-$238,131
Canceled cashflow
$3,699,405
Canceled cashflow
$29,225,000
Net loss for the
period
-$18,909,992
Purchase of short-term
investments
$29,463,131
Accounts payable and
accrued liabilities
-$1,577,018
Accretion of
premiums/discounts on short-term...
$501,314
Receivables
$112,456
Operating lease liability
-$85,796
Termination of lease (note 7)
$31,648
Buy us a coffee
ESSA Pharma Inc. (EPIX)
ESSA Pharma Inc. (EPIX)